How chemotherapy damages the central nervous system

Journal of Biology

Volumn 7, Issue 4, 2008, Pages

  Meyers, Christina A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUOROURACIL; ISOTRETINOIN; METHOTREXATE;

ATTENTION DISTURBANCE; BRAIN FUNCTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVOR; CLINICAL TRIAL; COGNITIVE DEFECT; COLON CANCER; DRUG WITHDRAWAL; HUMAN; HYPOACUSIS; LEARNING DISORDER; MEMORY DISORDER; MYELIN SHEATH; NERVE CELL LESION; NERVE CELL NECROSIS; NEURAL STEM CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SHORT COURSE THERAPY; SHORT SURVEY; SINGLE DRUG DOSE; CENTRAL NERVOUS SYSTEM; COGNITION; DRUG EFFECT; DRUG THERAPY; METABOLISM; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM; COGNITION; DRUG THERAPY; HUMANS; MYELIN SHEATH;

EID: 48549087564     PISSN: None     EISSN: 14754924     Source Type: Journal    
DOI: 10.1186/jbiol73     Document Type: Short Survey

References (21)

1. Long-term effects of treatments for childhood cancers. JA Alvarez RE Scully TL Miller FD Armstrong LS Constine DL Friedman SE Lipschultz, Curr Opin Pediatr 2007 19 23 31 10.1097/MOP.0b013e328013c89e 17224658
2. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. SB Schagen MJ Muller W Boogerd GJ Mellenbergh FSAM van Dam, J Natl Cancer Inst 2006 98 1742 1745 17148777
3. The cognitive sequelae of standard dose adjuvant chemotherapy in women with breast cancer: results of a prospective, randomized, longitudinal trial. JS Wefel R Lenzi R Theriault RN Davis CA Meyers, Cancer 2004 100 2292 2299 10.1002/cncr.20272 15160331
4. Neuropsychological impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. TA Ahles AJ Saykin CT Furstenberg B Cole LA Mott K Skalla MB Whedon S Bivens T Mitchell ER Greenberg PM Silberfarb, J Clin Oncol 2002 20 485 493 10.1200/JCO.20.2.485 11786578
5. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil on cognitive function in mice. G Winocur J Vardy MA Binns L Kerr I Tannock, Pharmacol Biochem Behav 2006 85 66 75 10.1016/j.pbb.2006.07.010 16935324
6. Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. AB Reiriz GK Reolon T Preissler JO Rosado JAP Henriques R Roesler G Schwartsmann, Clin Cancer Res 2006 12 5000 10.1158/1078-0432.CCR-06-0138 16914590
7. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. G Joshi R Sultana J Tangpong MP Cole DK St Clair M Vore S Estus DA Butterfield, Free Radical Res 2005 39 1147 1154 10.1080/10715760500143478
8. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. J Crandall Y Sakai J Zhang O Koul Y Mineur WE Crusio P McCaffrey, Proc Natl Acad Sci USA 2004 101 5111 5116 15051884 10.1073/pnas.0306336101
9. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Dietrich R Han Y Yang M Mayer-Pröschel M Noble, J Biol 2006 5 22 17125495 10.1186/jbiol50
10. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. R Han YM Yang J Dietrich A Luebke M Mayer-Pröschel M Noble, J Biol 2008 7 12
11. Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy. GD Lee DL Longo Y Wang JM Rifkind L Abdul-Raman JA Mamczarz KB Duffy EL Spangler DD Taub MP Mattson DK Ingram, Clin Cancer Res 2006 12 198 205 10.1158/1078-0432.CCR-05-1286 16397043
12. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. M Moleski, Arch Clin Neuropsychol 2000 15 603 630 10.1016/S0887-6177(99)00050-5 14590198
13. Cognitive deficits after postoperative chemotherapy for breast carcinoma. SB Schagen FS van Dam MJ Muller W Boogerd J Lindeboom PF Bruning, Cancer 1999 85 640 650 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2- G 10091737
14. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. SA Castellon PA Ganz JE Bower L Petersen L Abraham GA Greendale, J Clin Exp Neuropsychol 2004 26 955 969 15742545
15. ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. BP Kreukels HL Hamburger MB de Ruiter FS van Dam KR Ridderinkhof W Boogerd SB Schagen, Clin Neurophysiol 2008 119 533 541 10.1016/j.clinph.2007.11.011 18164658
16. Altered frontocortical, cerebellar and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. DH Silverman CJ Dy SA Castellon J Lai BS Pio L Abraham L Waddel Petersen MR Phelps PA Ganz, Breast Cancer Res Treat 2007 103 303 311 10.1007/s10549-006-9380-z 17009108
17. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. M Inagaki E Yoshikawa Y Matsuoka Y Sugawara T Nakano T Akechi N Wada S Imoto K Murakami Y Uchitomi, Cancer 2007 109 146 156 10.1002/cncr.22368 17131349
18. Hippocampal volumes smaller in chemotherapy patients. B Schneiderman, Lancet Oncol 2004 5 202 10.1016/S1470-2045(04)01443-3 15085849
19. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. AJ Saykin TA Ahles BC McDonald, Semin Clin Neuropsychiatr 2003 8 201 216
20. Hippocampal brain amines in methotrexate-induced learning and memory deficit. S Madhyastha SN Somayaji MS Rao K Nalini KL Bairy, Can J Physiol Pharmacol 2002 80 1076 1084 10.1139/y02-135 12489927
21. No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. E Yoshikawa Y Matsuoka M Inagaki T Nakano T Akechi M Kobayakawa M Fujimori N Nakaya N Akizuki S Imoto K Murakami Y Uchitomi, Breast Cancer Res Treat 2005 92 81 84 10.1007/s10549-005-1412-6 15980995